国产精品毛片在线完整版_亚洲人成人无码网在线观看_在线观看AV不卡网站永久_男人在线观看色热色

目錄多肽

多肽庫(kù)：http://m.geekblogtips.com/synthbio_Category_3965332_1.html

部門(mén)價(jià)目表：

Name Sequence Quantity Price(2mg)￥ Price(5mg)￥
c(RGDfC) c(RGDfC) 97% 500 800
c(RGDfK) c(RGDfK) 97% 500 800
c(RGDyC) c(RGDyC) 97% 500 800
c(RGDKC) c(RGDKC) 97% 500 800
iRGD c(CRGDKGPDC) 97% 1000 1500
3Flag DYKDDDDKGDYKDDDDKIDYKDDDDK 97% 500 1100
Gastrin 1, human Pyr-GPWLEEEEEAYGWMDF-CONH2 97% 500 900
HIV-1 TAT Protein Peptide NH2-YGRKKRRQRRR-COOH 97% 300 700
?-Amyloid (25-35) NH2-GSNKGAIIGLM-COOH 97% 300 700
MOG35-55 MEVGWYRSPFSRVVHLYRNGK 97% 500 1100
α-MSH Ac-SYSMEHFRWGKPV-CONH2 97% 300 700
Angiopep-2 NH2-TFFYGGSRGKRNNFKTEEY-COOH 97% 500 1100
β-Amyloid (1-28) DAEFRHDSGYEVHHQKLVFFAEDVGSNK 97% 1300 1600
β-Amyloid (1-40) DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV 95% 2000 3000
β-Amyloid (25-35) GSNKGAIIGLM 97% 500 900
β-Amyloid (1-42), rat DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA 95% 3500 5000
β-Amyloid (1-42), human DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA 95% 3500 5000
LL-37 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES 95% 1650 2000
Angiotensin I Converting Enzyme Inhibitor RPGFSPFR 97% 500 700
Angiotensin Converting Enzyme Inhibitor Glp-WPRPQIPP 97% 500 700
Acetalin-3 Ac-RFMWMK-NH2 97% 500 700
Acetalin-2 Ac-RFMWMR-NH2 97% 500 700
Acetalin-1 Ac-RFMWMT-NH2 97% 500 700
ACTH (18-39), human RPVKVYPNGAEDESAEAFPLEF 97% 500 1100
ACTH (6-24), human HFRWGKPVGKKRRPVKVYP 97% 500 1100
ACTH (4-10), human MEHFRWG 97% 300 500
ACTH (4-11), human MEHFRWGK 97% 300 500
ACTH (1-10), human SYSMEHFRWG 97% 500 700
ACTH (1-13), human SYSMEHFRWGKPV 97% 500 700
ACTH (1-16), human SYSMEHFRWGKPVGKK 97% 500 700
ACTH (1-17), human SYSMEHFRWGKPVGKKR 97% 500 700
ACTH (1-24), human SYSMEHFRWGKPVGKKRRPVKVYP 97% 500 1100
ACTH (1-39), human SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF 97% 1800 2000
ACTH (1-39), rat SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF 97% 1800 2000
N-Acetyl, ACTH (1-17), human Ac-SYSMEHFRWGKPVGKKR 97% 800 1000
Pro-Adrenomedullin (N-20), rat ARLDTSSQFRKKWNKWALSR-NH2 97% 850 1000
Pro-Adrenomedullin (N-20), porcine ARLDVAAEFRKKWNKWALSR-NH2 97% 850 1000
Pro-Adrenomedullin (N-20), human ARLDVASEFRKKWNKWALSR-NH2 97% 850 1000
Adrenomedullin (22-52), human TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 97% 1300 1500
Adrenomedullin (1-12), human YRQSMNNFQGLR 97% 500 700
Allatostatins/Allatostatin I APSGAQRLYGFGL-NH2 97% 500 700
Allatostatin IV DRLYSFGL-NH2 97% 500 700
Allatostatin II GDGRLYAFGL-NH2 97% 500 700
Allatostatin III GGSLYSFGL-NH2 97% 500 700
Magainin Spacer Peptide DAEAVGPEAFADQDLDEREVR 97% 800 1000
Histatin 5 DSHAKRHHGYKRKFHEKHHSHRGY 97% 1000 1200
Indolicidin ILPWKWPWWPWRR-NH2 97% 500 700
Angiotensin III, human RVYIHPF 97% 500 700
Angiotensin II, human DRVYIHPF 97% 500 700
Angiotensin I, human DRVYIHPFHL 97% 500 700
CD36 Peptide P (139-155) CNLAVAAASHIYQNQFVQ 97% 800 1000
Angiotensin II Antipeptide EGVYVHPV 97% 500 700
Angiotensin II (5-8), human IHPF 97% 500 700
CD36 Peptide P (93-110) YRVRFLAKENVTQDAEDNC 97% 800 1000
Biotinyl-Angiotensin I Biotin-DRVYIHPFHL 97% 800 1000
Fibrinogen-Binding Peptide EHIPA 97% 500 700
Anti-Inflammatory Peptide 1 MQMKKVLDS 97% 500 700
Cecropin P1, porcine SWLSKTAKKLENSAKKRISEGIAIAIQGGPR 97% 1400 1600
Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] KWKLFKKIGAVLKVL-NH2 97% 700 900
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS 97% 1000 1200
Magainin I GIGKFLHSAGKFGKAFVGEIMKS 97% 1000 1200
Lactoferricin, bovine, (BLFC) RRWQWRMKKLG 97% 500 700
Apelin-13, human, bovine QRPRLSHKGPMPF 97% 500 700
(Glp1)-Apelin-13, human, bovine Glp-RPRLSHKGPMPF 97% 500 700
α-Bag Cell Peptide (1-7) APRLRFY 97% 500 700
α-Bag Cell Peptide (1-8) APRLRFYS 97% 500 700
α-Bag Cell Peptide (1-9) APRLRFYSL 97% 500 700
γ-Bag Cell Factor RLRFD 97% 500 700
β-Bag Cell Factor RLRFH 97% 500 700
β-Amyloid (1-14) DAEFRHDSGYEVHH 97% 500 700
β-Amyloid (1-13) DAEFRHDSGYEVH 97% 500 700
β-Amyloid (1-12) DAEFRHDSGYEV 97% 500 700
β-Amyloid (1-11) DAEFRHDSGYE 97% 500 700
β-Amyloid (1-10) DAEFRHDSGY 97% 500 700
β-Amyloid (1-9) DAEFRHDSG 97% 500 700
β-Amyloid (1-20) DAEFRHDSGYEVHHQKLVFF 97% 850 1000
β-Amyloid (1-18) DAEFRHDSGYEVHHQKLV 97% 850 1000
Bombesin Glp-QRLGNQWAVGHLM-NH2 97% 850 1000
Osteocalcin (37-49), human GFQEAYRRFYGPV 97% 850 1000
Myelopeptide-2 (MP-2) LVVYPW 97% 500 700
Bone Gla Protein (45-49) FYGPV 97% 500 700
[Tyr38, Phe42,46] Bone Gla Protein YQEAFRRFFGPV 97% 500 700
[Tyr0] Bradykinin YRPPGFSPFR 97% 500 700
Bradykinin RPPGFSPFR 97% 500 700
[Thi5,8,DPhe7] Bradykinin RPPG-Thi-S-DPhe-Thi-R 97% 500 800
CART (55-76), rat IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) 97% 850 1100
Cholecystokinin, CCK Tetrapeptide (30-33) WMDF-NH2 97% 500 700
Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form DYMGWMDF-NH2 97% 500 700
Katacalcin DMSSDLERDHRPHVSMPQNAN 97% 800 1000
Calcitonin, rat CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) 97% 2200 2500
Calcitonin, human CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) 97% 2200 2500
Human CMV pp65 (495-503) NLVPMVATV 97% 500 700
a-Helical Corticotropin Releasing Factor (12-41) FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 97% 1800 2000
Cortistatin 29 (1-13) Glp-ERPPLQQPPHRD 97% 800 1000
Proinsulin C-Peptide (55-89), ?human RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR 97% 2200 2500
SMCY (950-960) (human) SPSVDKARAEL 97% 500 700
Delta-Sleep Inducing Peptide WAGGDASGE 97% 500 700
Dynorphin A (2-17), porcine GGFLRRIRPKLKWDNQ 97% 800 1000
Dynorphin (2-17), amide, porcine GGFLRRIRPKLKWDNQ-NH2 97% 800 1000
Dynorphin B (1-9) YGGFLRRQF 97% 500 700
Dynorphin A (1-13), porcine YGGFLRRIRPKLK 97% 800 1000
Dynorphin A (1-13), amide, porcine YGGFLRRIRPKLK-NH2 97% 800 1000
Dynorphin A (1-17) YGGFLRRIRPKLKWDNQ 97% 800 1000
Dynorphin A amide, porcine YGGFLRRIRPKLKWDNQ-NH2 97% 800 1000
IRL-1720 Ac-DKEAVYFAHLDIIW 97% 800 1000
Met-Enkephalin YGGFM 97% 500 700
EXENDIN (9-39) DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 97% 1800 2000
Exendin-4 HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 97% 1800 2000
Fibronectin CS1 Peptide EILDVPST 97% 500 700
G-R-G-D-S-P GRGDSP 97% 500 700
Collagen Binding Fragment CQDSETRTFY 97% 500 700
[Glu1] Fibrinopeptide B, human EGVNDNEEGFFSAR 97% 500 700
[Tyr0] Fibrinopeptide A, human YADSGEGDFLAEGGGVR 97% 800 1000
FMRF-amide FMRF-NH2 97% 500 700
Galantide GWTLNSAGYLLGPQQFFGLM-NH2 97% 850 1000
Galanin, rat GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 97% 1300 1600
Galanin, human GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS 97% 1300 1600
M40 GWTLNSAGYLLGPPPALALA-NH2 97% 900 1200
M35 GWTLNSAGYLLGPPPGFSPFR-NH2 97% 900 1200
GHRF (1-29), amide, rat HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 97% 1250 1600
GHRF (1-29), amide, human YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 97% 1250 1600
GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 97% 1400 1700
GLP-1 (7-36), amide, chicken, common turkey HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 97% 1400 1700
GLP-1/Glucagon-Like Peptide, human HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 97% 1600 2000
GLP-1/Glucagon-Like Peptide, amide, human HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 97% 1600 2000
[Des-His1,Glu9] Glucagon, amide SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 97% 1200 1500
GLP-2, human HADGSFSDEMNTILDNLAARDFINWLIQTKITD 97% 1600 2000
Glucagon-Like Peptide II, human HADGSFSDEMNTILDNLAARDFINWLIQTKITDR 97% 1600 2000
Glucagon-Like Peptide II, rat HADGSFSDEMNTILDNLATRDFINWLIQTKITD 97% 1600 2000
Glucagon, human HSQGTFTSDYSKYLDSRRAQDFVQWLMNT 97% 1250 1600
Epidermal Growth Factor Receptor Peptide (985-996) DVVDADEYLIPQ 97% 500 700
Brain Derived Acidic Fibroblast Growth Factor (1-11) FNLPLGNYKKP 97% 500 700
Brain Derived Basic Fibroblast Growth Factor (1-24) PALPEDGGSGAFPPGHFKDPKRLY 97% 1050 1300
Brain Derived Acidic Fibroblast Growth Factor (102-111) HAEKHWFVGL 97% 500 700
GTP-Binding Protein Fragment, Gs alpha CKQLQKDKQVYRATHR 97% 500 700
Histone H1-derived Peptide GGGPATPKKAKKL 97% 500 700
HIV-1 tat Protein (1-9) MDPVDPNIE 97% 500 700
HIV-1 gag Protein p24 (194-210) ANPDCKTILKALGPAAT 97% 750 1000
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) AVGIGALFLGFLGAAGSTMGARS-NH2 97% 1000 1200
HIV (gp41) Fragment AVGIGA 97% 500 700
HIV (gp120) Fragment (318-327) RGPGRAFVTI 97% 500 700
HIV-1 tat Protein (49-57) RKKRRQRRR 97% 500 700
Laminin (925-933) CDPGYIGSR 97% 500 700
Laminin A Chain (2091-2108) CSRARKQAASIKVAVSADR 97% 800 1000
Laminin (929-933) YIGSR 97% 500 700
Laminin Penta Peptide, amide YIGSR-NH2 97% 500 700
Leptin (93-105), human NVIQISNDLENLR 97% 500 700
Leptin (116-130), mouse SCSLPQTSGLQKPES 97% 650 850
Leucokinin I DPAFNSWG 97% 500 700
[DTrp6]-LH-RH, amide Glp-HWSY-DTrp-LRPG-NH2 97% 500 700
LH-RH, Free Acid Glp-HWSYGLRPG 97% 500 700
LH-RH, human, Gonadoreline Glp-HWSYGLRPG-NH2 97% 500 700
LH-RH, salmon Glp-HWSYGWLPG-NH2 97% 500 700
LH-RH, lamprey Glp-HYSLEWKPG-NH2 97% 500 700
Mast Cell Degranulating Peptide HR-1 INLKAIAALVKKVL-NH2 97% 600 800
Mast Cell Degranulating Peptide HR-2 FLPLILGKLVKGLL-NH2 97% 600 800
Melanocyte-Stimulating Hormone-Release Inhibiting Factor PLG-NH2 97% 500 700
MAGE-3 Antigen (167-176), human MEVDPIGHLY 97% 500 700
MAGE-3 Antigen (271-279), human FLWGPRALV 97% 500 700
Mage-1 Antigen (161-169), human EADPTGHSY 97% 500 700
(Met 210) Melanoctye Protein PMEL 17 (209-217) (human) IMDQVPFSV 97% 500 700
Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val ITDQVPFSV 97% 500 700
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp WNRQLYPEWTEAQRLD 97% 700 900
Systemin AVQSKPPSKRDPPKMQTD 97% 700 900
Flag Peptide DYKDDDDK 97% 500 700
OVA 323-339 ISQAVHAAHAEINEAGR 97% 700 900
OVA peptide (257-264) SIINFEKL 97% 500 700
Myelin Basic Protein (68-84), guinea pig YGSLPQKSQRSQDEN 97% 700 900
Hexa His HHHHHH 97% 500 700
Motilin, canine FVPIFTHSELQKIREKERNKGQ 97% 950 1150
Motilin, human, porcine FVPIFTYGELQRMQEKERNKGQ 97% 950 1150
Myelin Basic Protein (87-99) (human, bovine, rat) VHFFKNIVTPRTP 97% 500 700
Neurokinin B DMHDFFVGLM-NH2 97% 500 700
Neurokinin A / Substance K HKTDSFVGLM-NH2 97% 500 700
Neuromedin C GNHWAVGHLM-NH2 97% 500 700
Neuromedin B GNLWATGHFM-NH2 97% 500 700
Neuromedin N KIPYIL 97% 500 700
Neuromedin (U25), human FRVDEEFQSPFASQSRGYFLFRPRN-NH2 97% 1100 1300
Neuropeptide Y, human YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 97% 1600 1800
Neuropeptide Y (13-36), human PAEDMARYYSALRHYINLITRQRY-NH2 97% 1100 1300
Neuropeptide K, porcine DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 97% 1600 1800
Kassinin DVPKSDQFVGLM-NH2 97% 700 900
Nocistatin EQKQLQ 97% 500 700
Mastoparan INLKALAALAKKIL-NH2 97% 700 900
Mastoparan X INWKGIAAMAKKLL-NH2 97% 700 900
Neuropeptide FF FLFQPQRF-NH2 97% 500 700
Diazepam-Binding Inhibitor Fragment, human QATVGDINTERPGMLDFTGK 97% 850 1100
Men 10376 DY-DTrp-V-DTrp-DTrp-K-NH2 97% 500 700
Physalaemin Glp-ADPNKFYGLM-NH2 97% 500 700
Phyllomedusin Glp-NPNRFIGLM-NH2 97% 500 700
Corazonin Glp-TFQYSRGWTN-NH2 97% 500 700
Neurotensin (8-13) RRPYIL 97% 500 700
Obestatin (human) FNAPFDVGIKLSGVQYQQHSQAL-NH2 97% 1000 1300
Nociceptin / Orphanin FQ FGGFTGARKSARKLANQ 97% 750 1000
Orexin B, canine RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 97% 1200 1500
Orexin B, human RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 97% 1200 1500
PACAP (1-38), human, ovine, rat HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 97% 1700 2000
PACAP-Related Peptide (PRP), rat DVAHEILNEAYRKVLDQLSARKYLQSMVA 97% 1200 1500
PACAP-Related Peptide (PRP), human DVAHGILNEAYRKVLDQLSAGKHLQSLVA 97% 1200 1500
PACAP (1-27), human, ovine, rat HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 97% 1200 1500
PACAP (6-27), human, ovine, rat FTDSYSRYRKQMAVKKYLAAVL-NH2 97% 1200 1500
Chromostatin, bovine SDEDSDGDRPQASPGLGPGP 97% 1200 1500
Pancreatic Polypeptide (rat) APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 97% 1700 2000
Pancreatic Polypeptide (human) APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 97% 1700 2000
Insulin B (9 - 23) SHLVEALYLVCGERG 97% 650 900
PAR - 1 Agonist;Protease - Activated Receptor - 1 TFLLRN 97% 500 700
PAR-4 (1-6) amide (human) GYPGQV-NH2 97% 500 700
PAR-4 (1-6) (human) GYPGQV 97% 500 700
PAR-4 (1-6) amide (mouse) GYPGKF-NH2 97% 500 700
PAR-4 (1-6) (mouse) GYPGKF 97% 500 700
P34cdc2 Kinase Substrate Peptide ADAQHATPPKKKRKVEDPKDF 97% 750 1000
Tyrosinase (206-214), human AFLPWHRLF 97% 650 900
Substrate for Tyrosine Protein Kinase RRLIEDNEYTARG 97% 650 900
S6-1 RRLSSLRA 97% 650 900
Phosphate Acceptor Peptide RRKASGPPV 97% 650 900
Malantide RTKRSGSVYEPLKI 97% 650 900
Protease-Activated Receptor-2, PAR-2 Agonist, amide SLIGKV-NH2 97% 650 900
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 97% 1200 1500
Kemptide LRRASLG 97% 650 900
Phosphorylase Kinase b-Subunit (420-436) KRNPGSQKRFPSNCGRD 97% 750 1000
Myosin Kinase Inhibiting Peptide KKRAARATS-NH2 97% 650 900
Syntide 2 PLARTLSVAGLPGKK 97% 650 900
Tyrosinase (192-200), human mouse SEIWRDIDF 97% 650 900
Tyr-Ile-Tyr-Gly-Ser-Phe-Lys YIYGSFK 97% 500 700
Casein Kinase II Substrate RRREEETEEE 97% 650 900
Ser25] Protein Kinase C (19-31) RFARKGSLRQKNV 97% 650 900
[Ala9] Autocamtide 2 KKALRRQEAVDAL 97% 650 900
Autocamtide 2 KKALRRQETVDAL 97% 650 900
cAMP Dependent PK Inhibitor (5-22), amide TTYADFIASGRTGRRNAI-NH2 97% 800 1000
RR-SRC RRLIEDAEYAARG 97% 650 900
Protein Kinase C (19-35) Peptide RFARKGALRQKNVHEVK 97% 800 1000
Protein Kinase C (gamma) Peptide NYPLELYERVRTGC 97% 650 900
Hypercalcemia Malignancy Factor (1-34), human AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA 97% 1500 1800
Hypercalcemia Malignancy Factor (1-34), amide, human AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 97% 1500 1800
Parathyroid Hormone (1-34), rat AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF 97% 1500 1800
Parathyroid Hormone (1-34), bovine AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF 97% 1500 1800
Angiotensinogen (1-14), human DRVYIHPFHLVIHN 97% 650 900
Acetyl Angiotensinogen (1-14), porcine Ac-DRVYIHPFHLLVYS 97% 650 900
Acetyl, Angiotensinogen (1-14), human Ac-DRVYIHPFHLVIHN 97% 650 900
Renin Substrate Tetradecapeptide, rat DRVYIHPFHLLYYS 97% 650 900
Angiotensinogen (1-14), porcine DRVYIHPFHLLVYS 97% 650 900
Angiotensinogen (1-13), human DRVYIHPFHLVIH 97% 650 900
P-H-P-F-H-F-F-V-Y-K PHPFHFFVYK 97% 650 900
[Cys8] Renin Substrate Tetradecapeptide, rat DRVYIHPCHLLYYS 97% 650 900
[Leu8] Renin Substrate Tetradecapeptide, rat DRVYIHPLHLLYYS 97% 650 900
[Val8] Renin Substrate Tetradecapeptide, rat DRVYIHPVHLLYYS 97% 650 900
Secretin, rat HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 97% 1200 1400
Secretin (5-27), porcine TFTSELSRLRDSARLQRLLQGLV-NH2 97% 1200 1400
Secretin, human HSDGTFTSELSRLREGARLQRLLQGLV-NH2 97% 1200 1400
Selank TKPRPGP 97% 500 700
Somatostatin 28 (1-14) SANSNPAMAPRERK 97% 500 700
Somatostatin1-14 AGCKNFFWKTFTSC (C3&C14 bridge) 97% 1100 1400
RC-160 (Vapreotide) fCYwKVCW-NH2 (C2&C7 bridge) 97% 1100 1400
NTB (Naltriben) DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) 97% 1100 1400
[DPro2,DPhe7,DTrp9] Substance P R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 97% 650 900
MG-132 RPKPQQFFGLM-NH2 97% 650 900
Pep-1 KETWWETWWTEWSQPKKKRKV 97% 900 1100
TAT 2-4 YGRKKRRQRRRGYGRKKRRQRRRG 97% 900 1200
Scrambled TRAP Fragment FSLLRN-NH2 97% 500 700
Hemoglobin (Hb) (64-76) GKKVITAFNEGLK 97% 500 700
Thymopoietin II (32-34) RKD 97% 500 700
Thymopoietin II (32-35) RKDV 97% 500 700
Thymopentin RKDVY 97% 500 700
Urocortin II, human IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 97% 1900 2200
Urocortin III, mouse FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 97% 1900 2200
Urocortin III, human FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 97% 1900 2200
Urocortin, human DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 97% 1900 2200
Urocortin, rat DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 97% 1900 2200
Urocortin III, mouse, free acid FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI 97% 1900 2200
Urotensin I NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 97% 1900 2200
VIP, human, porcine, rat, ovine HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 97% 1200 1400
PHI, rat HADGVFTSDYSRLLGQISAKKYLESLI-NH2 97% 1200 1400
VIP, guinea pig HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 97% 1200 1400
Peptide T ASTTTNYT 97% 500 700
R15K, HIV-1 Inhibitory Peptide RIQRGPGRAFVTIGK 97% 650 900


95純度的參考價(jià)：

Name Sequence Quantity Weight Price
Angiotensin I Converting Enzyme Inhibitor RPGFSPFR ≥95.0% 1mg ￥120
Angiotensin I Converting Enzyme Inhibitor RPGFSPFR ≥95.0% 5mg ￥360
Angiotensin Converting Enzyme Inhibitor Glp-WPRPQIPP ≥95.0% 1mg ￥135
Angiotensin Converting Enzyme Inhibitor Glp-WPRPQIPP ≥95.0% 5mg ￥405
Acetalin-3 Ac-RFMWMK-NH2 ≥95.0% 1mg ￥110
Acetalin-3 Ac-RFMWMK-NH2 ≥95.0% 5mg ￥330
Acetalin-2 Ac-RFMWMR-NH2 ≥95.0% 1mg ￥110
Acetalin-2 Ac-RFMWMR-NH2 ≥95.0% 5mg ￥330
Acetalin-1 Ac-RFMWMT-NH2 ≥95.0% 1mg ￥110
Acetalin-1 Ac-RFMWMT-NH2 ≥95.0% 5mg ￥330
ACTH (18-39), human RPVKVYPNGAEDESAEAFPLEF ≥95.0% 1mg ￥330
ACTH (18-39), human RPVKVYPNGAEDESAEAFPLEF ≥95.0% 5mg ￥990
ACTH (6-24), human HFRWGKPVGKKRRPVKVYP ≥95.0% 1mg ￥285
ACTH (6-24), human HFRWGKPVGKKRRPVKVYP ≥95.0% 5mg ￥285
ACTH (4-10), human MEHFRWG ≥95.0% 1mg ￥105
ACTH (4-10), human MEHFRWG ≥95.0% 5mg ￥315
ACTH (4-11), human MEHFRWGK ≥95.0% 1mg ￥120
ACTH (4-11), human MEHFRWGK ≥95.0% 5mg ￥360
ACTH (1-10), human SYSMEHFRWG ≥95.0% 1mg ￥150
ACTH (1-10), human SYSMEHFRWG ≥95.0% 5mg ￥450
ACTH (1-13), human SYSMEHFRWGKPV ≥95.0% 1mg ￥165
ACTH (1-13), human SYSMEHFRWGKPV ≥95.0% 5mg ￥495
ACTH (1-16), human SYSMEHFRWGKPVGKK ≥95.0% 1mg ￥240
ACTH (1-16), human SYSMEHFRWGKPVGKK ≥95.0% 5mg ￥720
ACTH (1-17), human SYSMEHFRWGKPVGKKR ≥95.0% 1mg ￥255
ACTH (1-17), human SYSMEHFRWGKPVGKKR ≥95.0% 5mg ￥765
ACTH (1-24), human SYSMEHFRWGKPVGKKRRPVKVYP ≥95.0% 1mg ￥360
ACTH (1-24), human SYSMEHFRWGKPVGKKRRPVKVYP ≥95.0% 5mg ￥1,080
ACTH (1-39), human SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF ≥95.0% 1mg ￥624
ACTH (1-39), human SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF ≥95.0% 5mg ￥1,872
ACTH (1-39), rat SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF ≥95.0% 1mg ￥624
ACTH (1-39), rat SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF ≥95.0% 5mg ￥1,872
N-Acetyl, ACTH (1-17), human Ac-SYSMEHFRWGKPVGKKR ≥95.0% 1mg ￥255
N-Acetyl, ACTH (1-17), human Ac-SYSMEHFRWGKPVGKKR ≥95.0% 5mg ￥765
Pro-Adrenomedullin (N-20), rat ARLDTSSQFRKKWNKWALSR-NH2 ≥95.0% 1mg ￥312
Pro-Adrenomedullin (N-20), rat ARLDTSSQFRKKWNKWALSR-NH2 ≥95.0% 5mg ￥936
Pro-Adrenomedullin (N-20), porcine ARLDVAAEFRKKWNKWALSR-NH2 ≥95.0% 1mg ￥312
Pro-Adrenomedullin (N-20), porcine ARLDVAAEFRKKWNKWALSR-NH2 ≥95.0% 5mg ￥936
Pro-Adrenomedullin (N-20), human ARLDVASEFRKKWNKWALSR-NH2 ≥95.0% 1mg ￥312
Pro-Adrenomedullin (N-20), human ARLDVASEFRKKWNKWALSR-NH2 ≥95.0% 5mg ￥936
Adrenomedullin (22-52), human TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 ≥95.0% 1mg ￥527
Adrenomedullin (22-52), human TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 ≥95.0% 5mg ￥1,581
Adrenomedullin (1-12), human YRQSMNNFQGLR ≥95.0% 1mg ￥120
Adrenomedullin (1-12), human YRQSMNNFQGLR ≥95.0% 5mg ￥360
Allatostatins/Allatostatin I APSGAQRLYGFGL-NH2 ≥95.0% 1mg ￥205
Allatostatins/Allatostatin I APSGAQRLYGFGL-NH2 ≥95.0% 5mg ￥615
Allatostatin IV DRLYSFGL-NH2 ≥95.0% 1mg ￥130
Allatostatin IV DRLYSFGL-NH2 ≥95.0% 5mg ￥390
Allatostatin II GDGRLYAFGL-NH2 ≥95.0% 1mg ￥160
Allatostatin II GDGRLYAFGL-NH2 ≥95.0% 5mg ￥480
Allatostatin III GGSLYSFGL-NH2 ≥95.0% 1mg ￥145
Allatostatin III GGSLYSFGL-NH2 ≥95.0% 5mg ￥435
Magainin Spacer Peptide DAEAVGPEAFADQDLDEREVR ≥95.0% 1mg ￥316
Magainin Spacer Peptide DAEAVGPEAFADQDLDEREVR ≥95.0% 5mg ￥948
Histatin 5 DSHAKRHHGYKRKFHEKHHSHRGY ≥95.0% 1mg ￥360
Histatin 5 DSHAKRHHGYKRKFHEKHHSHRGY ≥95.0% 5mg ￥1,080
Indolicidin ILPWKWPWWPWRR-NH2 ≥95.0% 1mg ￥205
Indolicidin ILPWKWPWWPWRR-NH2 ≥95.0% 5mg ￥615
Angiotensin III, human RVYIHPF ≥95.0% 1mg ￥105
Angiotensin III, human RVYIHPF ≥95.0% 5mg ￥315
Angiotensin II, human DRVYIHPF ≥95.0% 1mg ￥120
Angiotensin II, human DRVYIHPF ≥95.0% 5mg ￥360
Angiotensin I, human DRVYIHPFHL ≥95.0% 1mg ￥150
Angiotensin I, human DRVYIHPFHL ≥95.0% 5mg ￥450
CD36 Peptide P (139-155) CNLAVAAASHIYQNQFVQ ≥95.0% 1mg ￥255
CD36 Peptide P (139-155) CNLAVAAASHIYQNQFVQ ≥95.0% 5mg ￥765
Angiotensin II Antipeptide EGVYVHPV ≥95.0% 1mg ￥120
Angiotensin II Antipeptide EGVYVHPV ≥95.0% 5mg ￥360
Angiotensin II (5-8), human IHPF ≥95.0% 1mg ￥60
Angiotensin II (5-8), human IHPF ≥95.0% 5mg ￥180
CD36 Peptide P (93-110) YRVRFLAKENVTQDAEDNC ≥95.0% 1mg ￥270
CD36 Peptide P (93-110) YRVRFLAKENVTQDAEDNC ≥95.0% 5mg ￥810
Biotinyl-Angiotensin I Biotin-DRVYIHPFHL ≥95.0% 1mg ￥175
Biotinyl-Angiotensin I Biotin-DRVYIHPFHL ≥95.0% 5mg ￥525
Fibrinogen-Binding Peptide EHIPA ≥95.0% 1mg ￥75
Fibrinogen-Binding Peptide EHIPA ≥95.0% 5mg ￥225
Anti-Inflammatory Peptide 1 MQMKKVLDS ≥95.0% 1mg ￥135
Anti-Inflammatory Peptide 1 MQMKKVLDS ≥95.0% 5mg ￥405
Cecropin P1, porcine SWLSKTAKKLENSAKKRISEGIAIAIQGGPR ≥95.0% 1mg ￥480
Cecropin P1, porcine SWLSKTAKKLENSAKKRISEGIAIAIQGGPR ≥95.0% 5mg ￥1,440
Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] KWKLFKKIGAVLKVL-NH2 ≥95.0% 1mg ￥235
Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] KWKLFKKIGAVLKVL-NH2 ≥95.0% 5mg ￥705
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS ≥95.0% 1mg ￥368
Magainin 2 GIGKFLHSAKKFGKAFVGEIMNS ≥95.0% 5mg ￥1,104
Magainin I GIGKFLHSAGKFGKAFVGEIMKS ≥95.0% 1mg ￥368
Magainin I GIGKFLHSAGKFGKAFVGEIMKS ≥95.0% 5mg ￥1,104
Lactoferricin, bovine, (BLFC) RRWQWRMKKLG ≥95.0% 1mg ￥165
Lactoferricin, bovine, (BLFC) RRWQWRMKKLG ≥95.0% 5mg ￥495
Apelin-13, human, bovine QRPRLSHKGPMPF ≥95.0% 1mg ￥195
Apelin-13, human, bovine QRPRLSHKGPMPF ≥95.0% 5mg ￥585
(Glp1)-Apelin-13, human, bovine Glp-RPRLSHKGPMPF ≥95.0% 1mg ￥220
(Glp1)-Apelin-13, human, bovine Glp-RPRLSHKGPMPF ≥95.0% 5mg ￥660
α-Bag Cell Peptide (1-7) APRLRFY ≥95.0% 1mg ￥105
α-Bag Cell Peptide (1-7) APRLRFY ≥95.0% 5mg ￥315
α-Bag Cell Peptide (1-8) APRLRFYS ≥95.0% 1mg ￥120
α-Bag Cell Peptide (1-8) APRLRFYS ≥95.0% 5mg ￥360
α-Bag Cell Peptide (1-9) APRLRFYSL ≥95.0% 1mg ￥135
α-Bag Cell Peptide (1-9) APRLRFYSL ≥95.0% 5mg ￥405
γ-Bag Cell Factor RLRFD ≥95.0% 1mg ￥75
γ-Bag Cell Factor RLRFD ≥95.0% 5mg ￥225
β-Bag Cell Factor RLRFH ≥95.0% 1mg ￥75
β-Bag Cell Factor RLRFH ≥95.0% 5mg ￥225
β-Amyloid (1-14) DAEFRHDSGYEVHH ≥95.0% 1mg ￥280
β-Amyloid (1-14) DAEFRHDSGYEVHH ≥95.0% 5mg ￥840
β-Amyloid (1-13) DAEFRHDSGYEVH ≥95.0% 1mg ￥260
β-Amyloid (1-13) DAEFRHDSGYEVH ≥95.0% 5mg ￥780
β-Amyloid (1-12) DAEFRHDSGYEV ≥95.0% 1mg ￥240
β-Amyloid (1-12) DAEFRHDSGYEV ≥95.0% 5mg ￥720
β-Amyloid (1-11) DAEFRHDSGYE ≥95.0% 1mg ￥220
β-Amyloid (1-11) DAEFRHDSGYE ≥95.0% 5mg ￥660
β-Amyloid (1-10) DAEFRHDSGY ≥95.0% 1mg ￥200
β-Amyloid (1-10) DAEFRHDSGY ≥95.0% 5mg ￥600
β-Amyloid (1-9) DAEFRHDSG ≥95.0% 1mg ￥180
β-Amyloid (1-9) DAEFRHDSG ≥95.0% 5mg ￥540
β-Amyloid (1-20) DAEFRHDSGYEVHHQKLVFF ≥95.0% 1mg ￥400
β-Amyloid (1-20) DAEFRHDSGYEVHHQKLVFF ≥95.0% 5mg ￥1,200
β-Amyloid (1-18) DAEFRHDSGYEVHHQKLV ≥95.0% 1mg ￥360
β-Amyloid (1-18) DAEFRHDSGYEVHHQKLV ≥95.0% 5mg ￥1,080
Bombesin Glp-QRLGNQWAVGHLM-NH2 ≥95.0% 1mg ￥254
Bombesin Glp-QRLGNQWAVGHLM-NH2 ≥95.0% 5mg ￥762
Osteocalcin (37-49), human GFQEAYRRFYGPV ≥95.0% 1mg ￥195
Osteocalcin (37-49), human GFQEAYRRFYGPV ≥95.0% 5mg ￥585
Myelopeptide-2 (MP-2) LVVYPW ≥95.0% 1mg ￥90
Myelopeptide-2 (MP-2) LVVYPW ≥95.0% 5mg ￥270
Bone Gla Protein (45-49) FYGPV ≥95.0% 1mg ￥75
Bone Gla Protein (45-49) FYGPV ≥95.0% 5mg ￥225
[Tyr38, Phe42,46] Bone Gla Protein YQEAFRRFFGPV ≥95.0% 1mg ￥180
[Tyr38, Phe42,46] Bone Gla Protein YQEAFRRFFGPV ≥95.0% 5mg ￥540
[Tyr0] Bradykinin YRPPGFSPFR ≥95.0% 1mg ￥150
[Tyr0] Bradykinin YRPPGFSPFR ≥95.0% 5mg ￥450
Bradykinin RPPGFSPFR ≥95.0% 1mg ￥135
Bradykinin RPPGFSPFR ≥95.0% 5mg ￥405
[Thi5,8,DPhe7] Bradykinin RPPG-Thi-S-DPhe-Thi-R ≥95.0% 1mg ￥210
[Thi5,8,DPhe7] Bradykinin RPPG-Thi-S-DPhe-Thi-R ≥95.0% 5mg ￥630
Fam-Bradykinin 5FAM-RPPGFSPFR ≥95.0% 1mg ￥235
Fam-Bradykinin 5FAM-RPPGFSPFR ≥95.0% 5mg ￥705
CART (55-76), rat IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) ≥95.0% 1mg ￥352
CART (55-76), rat IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) ≥95.0% 5mg ￥1,056
Cholecystokinin, CCK Tetrapeptide (30-33) WMDF-NH2 ≥95.0% 1mg ￥70
Cholecystokinin, CCK Tetrapeptide (30-33) WMDF-NH2 ≥95.0% 5mg ￥210
Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form DYMGWMDF-NH2 ≥95.0% 1mg ￥130
Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form DYMGWMDF-NH2 ≥95.0% 5mg ￥390
Katacalcin DMSSDLERDHRPHVSMPQNAN ≥95.0% 1mg ￥315
Katacalcin DMSSDLERDHRPHVSMPQNAN ≥95.0% 5mg ￥945
Calcitonin, rat CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) ≥95.0% 1mg ￥664
Calcitonin, rat CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) ≥95.0% 5mg ￥1,992
Calcitonin, human CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) ≥95.0% 1mg ￥664
Calcitonin, human CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) ≥95.0% 5mg ￥1,992
Human CMV pp65 (495-503) NLVPMVATV ≥95.0% 1mg ￥135
Human CMV pp65 (495-503) NLVPMVATV ≥95.0% 5mg ￥405
a-Helical Corticotropin Releasing Factor (12-41) FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 ≥95.0% 1mg ￥492
a-Helical Corticotropin Releasing Factor (12-41) FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 ≥95.0% 5mg ￥1,476
Cortistatin 29 (1-13) Glp-ERPPLQQPPHRD ≥95.0% 1mg ￥195
Cortistatin 29 (1-13) Glp-ERPPLQQPPHRD ≥95.0% 5mg ￥585
Proinsulin C-Peptide (55-89), ?human RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR ≥95.0% 1mg ￥630
Proinsulin C-Peptide (55-89), ?human RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR ≥95.0% 5mg ￥1,890
SMCY (950-960) (human) SPSVDKARAEL ≥95.0% 1mg ￥165
SMCY (950-960) (human) SPSVDKARAEL ≥95.0% 5mg ￥495
Delta-Sleep Inducing Peptide WAGGDASGE ≥95.0% 1mg ￥135
Delta-Sleep Inducing Peptide WAGGDASGE ≥95.0% 5mg ￥405
DISP WAGGDASGE ≥98.0% 1mg ￥162
DISP WAGGDASGE ≥98.0% 5mg ￥486
Dynorphin A (2-17), porcine GGFLRRIRPKLKWDNQ ≥95.0% 1mg ￥240
Dynorphin A (2-17), porcine GGFLRRIRPKLKWDNQ ≥95.0% 5mg ￥720
Dynorphin (2-17), amide, porcine GGFLRRIRPKLKWDNQ-NH2 ≥95.0% 1mg ￥250
Dynorphin (2-17), amide, porcine GGFLRRIRPKLKWDNQ-NH2 ≥95.0% 5mg ￥750
Dynorphin B (1-9) YGGFLRRQF ≥95.0% 1mg ￥135
Dynorphin B (1-9) YGGFLRRQF ≥95.0% 5mg ￥405
Dynorphin A (1-13), porcine YGGFLRRIRPKLK ≥95.0% 1mg ￥195
Dynorphin A (1-13), porcine YGGFLRRIRPKLK ≥95.0% 5mg ￥585
Dynorphin A (1-13), amide, porcine YGGFLRRIRPKLK-NH2 ≥95.0% 1mg ￥205
Dynorphin A (1-13), amide, porcine YGGFLRRIRPKLK-NH2 ≥95.0% 5mg ￥615
Dynorphin A (1-17) YGGFLRRIRPKLKWDNQ ≥95.0% 1mg ￥255
Dynorphin A (1-17) YGGFLRRIRPKLKWDNQ ≥95.0% 5mg ￥765
Dynorphin A amide, porcine YGGFLRRIRPKLKWDNQ-NH2 ≥95.0% 1mg ￥265
Dynorphin A amide, porcine YGGFLRRIRPKLKWDNQ-NH2 ≥95.0% 5mg ￥795
IRL-1720 Ac-DKEAVYFAHLDIIW ≥95.0% 1mg ￥225
IRL-1720 Ac-DKEAVYFAHLDIIW ≥95.0% 5mg ￥675
Met-Enkephalin YGGFM ≥95.0% 1mg ￥75
Met-Enkephalin YGGFM ≥95.0% 5mg ￥225
EXENDIN (9-39) DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 ≥95.0% 1mg ￥527
EXENDIN (9-39) DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 ≥95.0% 5mg ￥1,581
Exendin-4 HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 ≥95.0% 1mg ￥720
Exendin-4 HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 ≥95.0% 5mg ￥2,160
Fibronectin CS1 Peptide EILDVPST ≥95.0% 1mg ￥120
Fibronectin CS1 Peptide EILDVPST ≥95.0% 5mg ￥360
G-R-G-D-S-P GRGDSP ≥95.0% 1mg ￥90
G-R-G-D-S-P GRGDSP ≥95.0% 5mg ￥270
Collagen Binding Fragment CQDSETRTFY ≥95.0% 1mg ￥150
Collagen Binding Fragment CQDSETRTFY ≥95.0% 5mg ￥450
[Glu1] Fibrinopeptide B, human EGVNDNEEGFFSAR ≥95.0% 1mg ￥210
[Glu1] Fibrinopeptide B, human EGVNDNEEGFFSAR ≥95.0% 5mg ￥630
[Tyr0] Fibrinopeptide A, human YADSGEGDFLAEGGGVR ≥95.0% 1mg ￥255
[Tyr0] Fibrinopeptide A, human YADSGEGDFLAEGGGVR ≥95.0% 5mg ￥765
FMRF-amide FMRF-NH2 ≥95.0% 1mg ￥70
FMRF-amide FMRF-NH2 ≥95.0% 5mg ￥210
Galantide GWTLNSAGYLLGPQQFFGLM-NH2 ≥95.0% 1mg ￥330
Galantide GWTLNSAGYLLGPQQFFGLM-NH2 ≥95.0% 5mg ￥990
Galanin, rat GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 ≥95.0% 1mg ￥474
Galanin, rat GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 ≥95.0% 5mg ￥1,422
Galanin, human GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS ≥95.0% 1mg ￥510
Galanin, human GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS ≥95.0% 5mg ￥1,530
M40 GWTLNSAGYLLGPPPALALA-NH2 ≥95.0% 1mg ￥310
M40 GWTLNSAGYLLGPPPALALA-NH2 ≥95.0% 5mg ￥930
M35 GWTLNSAGYLLGPPPGFSPFR-NH2 ≥95.0% 1mg ￥326
M35 GWTLNSAGYLLGPPPGFSPFR-NH2 ≥95.0% 5mg ￥978
GHRF (1-29), amide, rat HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 ≥95.0% 1mg ￥474
GHRF (1-29), amide, rat HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 ≥95.0% 5mg ￥1,422
GHRF (1-29), amide, human YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 ≥95.0% 1mg ￥474
GHRF (1-29), amide, human YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 ≥95.0% 5mg ￥1,422
GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG ≥95.0% 1mg ￥527
GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG ≥95.0% 5mg ￥1,581
GLP-1 (7-36), amide, chicken, common turkey HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 ≥95.0% 1mg ￥510
GLP-1 (7-36), amide, chicken, common turkey HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 ≥95.0% 5mg ￥1,530
GLP-1/Glucagon-Like Peptide, human HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG ≥95.0% 1mg ￥660
GLP-1/Glucagon-Like Peptide, human HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG ≥95.0% 5mg ￥1,980
GLP-1/Glucagon-Like Peptide, amide, human HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 ≥95.0% 1mg ￥680
GLP-1/Glucagon-Like Peptide, amide, human HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 ≥95.0% 5mg ￥2,040
[Des-His1,Glu9] Glucagon, amide SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 ≥95.0% 1mg ￥680
[Des-His1,Glu9] Glucagon, amide SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 ≥95.0% 5mg ￥2,040
GLP-2, human HADGSFSDEMNTILDNLAARDFINWLIQTKITD ≥95.0% 1mg ￥561
GLP-2, human HADGSFSDEMNTILDNLAARDFINWLIQTKITD ≥95.0% 5mg ￥1,683
Glucagon-Like Peptide II, human HADGSFSDEMNTILDNLAARDFINWLIQTKITDR ≥95.0% 1mg ￥578
Glucagon-Like Peptide II, human HADGSFSDEMNTILDNLAARDFINWLIQTKITDR ≥95.0% 5mg ￥1,734
Glucagon-Like Peptide II, rat HADGSFSDEMNTILDNLATRDFINWLIQTKITD ≥95.0% 1mg ￥561
Glucagon-Like Peptide II, rat HADGSFSDEMNTILDNLATRDFINWLIQTKITD ≥95.0% 5mg ￥1,683
Glucagon, human HSQGTFTSDYSKYLDSRRAQDFVQWLMNT ≥95.0% 1mg ￥464
Glucagon, human HSQGTFTSDYSKYLDSRRAQDFVQWLMNT ≥95.0% 5mg ￥1,392
Epidermal Growth Factor Receptor Peptide (985-996) DVVDADEYLIPQ ≥95.0% 1mg ￥180
Epidermal Growth Factor Receptor Peptide (985-996) DVVDADEYLIPQ ≥95.0% 5mg ￥540
Brain Derived Acidic Fibroblast Growth Factor (1-11) FNLPLGNYKKP ≥95.0% 1mg ￥165
Brain Derived Acidic Fibroblast Growth Factor (1-11) FNLPLGNYKKP ≥95.0% 5mg ￥495
Brain Derived Basic Fibroblast Growth Factor (1-24) PALPEDGGSGAFPPGHFKDPKRLY ≥95.0% 1mg ￥360
Brain Derived Basic Fibroblast Growth Factor (1-24) PALPEDGGSGAFPPGHFKDPKRLY ≥95.0% 5mg ￥1,080
Brain Derived Acidic Fibroblast Growth Factor (102-111) HAEKHWFVGL ≥95.0% 1mg ￥150
Brain Derived Acidic Fibroblast Growth Factor (102-111) HAEKHWFVGL ≥95.0% 5mg ￥450
GTP-Binding Protein Fragment, Gs alpha CKQLQKDKQVYRATHR ≥95.0% 1mg ￥240
GTP-Binding Protein Fragment, Gs alpha CKQLQKDKQVYRATHR ≥95.0% 5mg ￥720
Histone H1-derived Peptide GGGPATPKKAKKL ≥95.0% 1mg ￥165
Histone H1-derived Peptide GGGPATPKKAKKL ≥95.0% 5mg ￥495
HIV-1 tat Protein (1-9) MDPVDPNIE ≥95.0% 1mg ￥135
HIV-1 tat Protein (1-9) MDPVDPNIE ≥95.0% 5mg ￥405
HIV-1 gag Protein p24 (194-210) ANPDCKTILKALGPAAT ≥95.0% 1mg ￥255
HIV-1 gag Protein p24 (194-210) ANPDCKTILKALGPAAT ≥95.0% 5mg ￥765
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) AVGIGALFLGFLGAAGSTMGARS-NH2 ≥95.0% 1mg ￥378
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) AVGIGALFLGFLGAAGSTMGARS-NH2 ≥95.0% 5mg ￥1,134
HIV (gp41) Fragment AVGIGA ≥95.0% 1mg ￥120
HIV (gp41) Fragment AVGIGA ≥95.0% 5mg ￥360
HIV (gp120) Fragment (318-327) RGPGRAFVTI ≥95.0% 1mg ￥150
HIV (gp120) Fragment (318-327) RGPGRAFVTI ≥95.0% 5mg ￥450
HIV-1 tat Protein (49-57) RKKRRQRRR ≥95.0% 1mg ￥135
HIV-1 tat Protein (49-57) RKKRRQRRR ≥95.0% 5mg ￥405
Laminin (925-933) CDPGYIGSR ≥95.0% 1mg ￥135
Laminin (925-933) CDPGYIGSR ≥95.0% 5mg ￥405
Laminin A Chain (2091-2108) CSRARKQAASIKVAVSADR ≥95.0% 1mg ￥270
Laminin A Chain (2091-2108) CSRARKQAASIKVAVSADR ≥95.0% 5mg ￥810
Laminin (929-933) YIGSR ≥95.0% 1mg ￥75
Laminin (929-933) YIGSR ≥95.0% 5mg ￥225
Laminin Penta Peptide, amide YIGSR-NH2 ≥95.0% 1mg ￥85
Laminin Penta Peptide, amide YIGSR-NH2 ≥95.0% 5mg ￥255
名稱 序列（一個(gè)字母） 純度 量 ￥參考價(jià)
Leptin (93-105), human NVIQISNDLENLR ≥95.0% 1mg ￥195
Leptin (93-105), human NVIQISNDLENLR ≥95.0% 5mg ￥585
Leptin (116-130), mouse SCSLPQTSGLQKPES ≥95.0% 1mg ￥225
Leptin (116-130), mouse SCSLPQTSGLQKPES ≥95.0% 5mg ￥675
Leucokinin I DPAFNSWG ≥95.0% 1mg ￥130
Leucokinin I DPAFNSWG ≥95.0% 5mg ￥390
[DTrp6]-LH-RH, amide Glp-HWSY-DTrp-LRPG-NH2 ≥95.0% 1mg ￥210
[DTrp6]-LH-RH, amide Glp-HWSY-DTrp-LRPG-NH2 ≥95.0% 5mg ￥630
LH-RH, Free Acid Glp-HWSYGLRPG ≥95.0% 1mg ￥165
LH-RH, Free Acid Glp-HWSYGLRPG ≥95.0% 5mg ￥495
LH-RH, human, Gonadoreline Glp-HWSYGLRPG-NH2 ≥95.0% 1mg ￥175
LH-RH, human, Gonadoreline Glp-HWSYGLRPG-NH2 ≥95.0% 5mg ￥525
LH-RH, salmon Glp-HWSYGWLPG-NH2 ≥95.0% 1mg ￥175
LH-RH, salmon Glp-HWSYGWLPG-NH2 ≥95.0% 5mg ￥525
LH-RH, lamprey Glp-HYSLEWKPG-NH2 ≥95.0% 1mg ￥175
LH-RH, lamprey Glp-HYSLEWKPG-NH2 ≥95.0% 5mg ￥525
Mast Cell Degranulating Peptide HR-1 INLKAIAALVKKVL-NH2 ≥95.0% 1mg ￥225
Mast Cell Degranulating Peptide HR-1 INLKAIAALVKKVL-NH2 ≥95.0% 5mg ￥675
Mast Cell Degranulating Peptide HR-2 FLPLILGKLVKGLL-NH2 ≥95.0% 1mg ￥225
Mast Cell Degranulating Peptide HR-2 FLPLILGKLVKGLL-NH2 ≥95.0% 5mg ￥675
Melanocyte-Stimulating Hormone-Release Inhibiting Factor PLG-NH2 ≥95.0% 1mg ￥55
Melanocyte-Stimulating Hormone-Release Inhibiting Factor PLG-NH2 ≥95.0% 5mg ￥165
MAGE-3 Antigen (167-176), human MEVDPIGHLY ≥95.0% 1mg ￥150
MAGE-3 Antigen (167-176), human MEVDPIGHLY ≥95.0% 5mg ￥450
MAGE-3 Antigen (271-279), human FLWGPRALV ≥95.0% 1mg ￥135
MAGE-3 Antigen (271-279), human FLWGPRALV ≥95.0% 5mg ￥405
Mage-1 Antigen (161-169), human EADPTGHSY ≥95.0% 1mg ￥135
Mage-1 Antigen (161-169), human EADPTGHSY ≥95.0% 5mg ￥405
(Met 210) Melanoctye Protein PMEL 17 (209-217) (human) IMDQVPFSV ≥95.0% 1mg ￥135
(Met 210) Melanoctye Protein PMEL 17 (209-217) (human) IMDQVPFSV ≥95.0% 5mg ￥405
Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val ITDQVPFSV ≥95.0% 1mg ￥135
Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val ITDQVPFSV ≥95.0% 5mg ￥405
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp WNRQLYPEWTEAQRLD ≥95.0% 1mg ￥240
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp WNRQLYPEWTEAQRLD ≥95.0% 5mg ￥720
Systemin AVQSKPPSKRDPPKMQTD ≥95.0% 1mg ￥270
Systemin AVQSKPPSKRDPPKMQTD ≥95.0% 5mg ￥810
Flag Peptide DYKDDDDK ≥95.0% 1mg ￥120
Flag Peptide DYKDDDDK ≥95.0% 5mg ￥360
OVA 323-339 ISQAVHAAHAEINEAGR ≥95.0% 1mg ￥272
OVA 323-339 ISQAVHAAHAEINEAGR ≥95.0% 5mg ￥816
OVA peptide (257-264) SIINFEKL ≥95.0% 1mg ￥120
OVA peptide (257-264) SIINFEKL ≥95.0% 5mg ￥360
Myelin Basic Protein (68-84), guinea pig YGSLPQKSQRSQDEN ≥95.0% 1mg ￥225
Myelin Basic Protein (68-84), guinea pig YGSLPQKSQRSQDEN ≥95.0% 5mg ￥675
Hexa His HHHHHH ≥95.0% 1mg ￥120
Hexa His HHHHHH ≥95.0% 5mg ￥360
MOG 35-55 MEVGWYRSPFSRVVHLYRNGK ≥95.0% 1mg ￥336
MOG 35-55 MEVGWYRSPFSRVVHLYRNGK ≥95.0% 5mg ￥1,008
Motilin, canine FVPIFTHSELQKIREKERNKGQ ≥95.0% 1mg ￥330
Motilin, canine FVPIFTHSELQKIREKERNKGQ ≥95.0% 5mg ￥990
Motilin, human, porcine FVPIFTYGELQRMQEKERNKGQ ≥95.0% 1mg ￥352
Motilin, human, porcine FVPIFTYGELQRMQEKERNKGQ ≥95.0% 5mg ￥1,056
Myelin Basic Protein (87-99) (human, bovine, rat) VHFFKNIVTPRTP ≥95.0% 1mg ￥195
Myelin Basic Protein (87-99) (human, bovine, rat) VHFFKNIVTPRTP ≥95.0% 5mg ￥585
Neurokinin B DMHDFFVGLM-NH2 ≥95.0% 1mg ￥165
Neurokinin B DMHDFFVGLM-NH2 ≥95.0% 5mg ￥495
Neurokinin A / Substance K HKTDSFVGLM-NH2 ≥95.0% 1mg ￥160
Neurokinin A / Substance K HKTDSFVGLM-NH2 ≥95.0% 5mg ￥480
Neuromedin C GNHWAVGHLM-NH2 ≥95.0% 1mg ￥160
Neuromedin C GNHWAVGHLM-NH2 ≥95.0% 5mg ￥480
Neuromedin B GNLWATGHFM-NH2 ≥95.0% 1mg ￥160
Neuromedin B GNLWATGHFM-NH2 ≥95.0% 5mg ￥480
Neuromedin N KIPYIL ≥95.0% 1mg ￥90
Neuromedin N KIPYIL ≥95.0% 5mg ￥270
Neuromedin (U25), human FRVDEEFQSPFASQSRGYFLFRPRN-NH2 ≥95.0% 1mg ￥400
Neuromedin (U25), human FRVDEEFQSPFASQSRGYFLFRPRN-NH2 ≥95.0% 5mg ￥1,200
Neuropeptide Y, human YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 ≥95.0% 1mg ￥664
Neuropeptide Y, human YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 ≥95.0% 5mg ￥1,992
Neuropeptide Y (13-36), human PAEDMARYYSALRHYINLITRQRY-NH2 ≥95.0% 1mg ￥360
Neuropeptide Y (13-36), human PAEDMARYYSALRHYINLITRQRY-NH2 ≥95.0% 5mg ￥1,080
Neuropeptide K, porcine DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 ≥95.0% 1mg ￥598
Neuropeptide K, porcine DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 ≥95.0% 5mg ￥1,794
Kassinin DVPKSDQFVGLM-NH2 ≥95.0% 1mg ￥195
Kassinin DVPKSDQFVGLM-NH2 ≥95.0% 5mg ￥585
Nocistatin EQKQLQ ≥95.0% 1mg ￥90
Nocistatin EQKQLQ ≥95.0% 5mg ￥270
Mastoparan INLKALAALAKKIL-NH2 ≥95.0% 1mg ￥220
Mastoparan INLKALAALAKKIL-NH2 ≥95.0% 5mg ￥660
Mastoparan X INWKGIAAMAKKLL-NH2 ≥95.0% 1mg ￥220
Mastoparan X INWKGIAAMAKKLL-NH2 ≥95.0% 5mg ￥660
Neuropeptide FF FLFQPQRF-NH2 ≥95.0% 1mg ￥130
Neuropeptide FF FLFQPQRF-NH2 ≥95.0% 5mg ￥390
Diazepam-Binding Inhibitor Fragment, human QATVGDINTERPGMLDFTGK ≥95.0% 1mg ￥320
Diazepam-Binding Inhibitor Fragment, human QATVGDINTERPGMLDFTGK ≥95.0% 5mg ￥960
Men 10376 DY-DTrp-V-DTrp-DTrp-K-NH2 ≥95.0% 1mg ￥205
Men 10376 DY-DTrp-V-DTrp-DTrp-K-NH2 ≥95.0% 5mg ￥615
Physalaemin Glp-ADPNKFYGLM-NH2 ≥95.0% 1mg ￥205
Physalaemin Glp-ADPNKFYGLM-NH2 ≥95.0% 5mg ￥615
Phyllomedusin Glp-NPNRFIGLM-NH2 ≥95.0% 1mg ￥190
Phyllomedusin Glp-NPNRFIGLM-NH2 ≥95.0% 5mg ￥570
Corazonin Glp-TFQYSRGWTN-NH2 ≥95.0% 1mg ￥205
Corazonin Glp-TFQYSRGWTN-NH2 ≥95.0% 5mg ￥615
Neurotensin (8-13) RRPYIL ≥95.0% 1mg ￥90
Neurotensin (8-13) RRPYIL ≥95.0% 5mg ￥270
Obestatin (human) FNAPFDVGIKLSGVQYQQHSQAL-NH2 ≥95.0% 1mg ￥378
Obestatin (human) FNAPFDVGIKLSGVQYQQHSQAL-NH2 ≥95.0% 5mg ￥1,134
Nociceptin / Orphanin FQ FGGFTGARKSARKLANQ ≥95.0% 1mg ￥254
Nociceptin / Orphanin FQ FGGFTGARKSARKLANQ ≥95.0% 5mg ￥762
Orexin B, canine RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 ≥95.0% 1mg ￥458
Orexin B, canine RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 ≥95.0% 5mg ￥1,374
Orexin B, human RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 ≥95.0% 1mg ￥458
Orexin B, human RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 ≥95.0% 5mg ￥1,374
PACAP (1-38), human, ovine, rat HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 ≥95.0% 1mg ￥684
PACAP (1-38), human, ovine, rat HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 ≥95.0% 5mg ￥2,052
PACAP-Related Peptide (PRP), rat DVAHEILNEAYRKVLDQLSARKYLQSMVA ≥95.0% 1mg ￥464
PACAP-Related Peptide (PRP), rat DVAHEILNEAYRKVLDQLSARKYLQSMVA ≥95.0% 5mg ￥1,392
PACAP-Related Peptide (PRP), human DVAHGILNEAYRKVLDQLSAGKHLQSLVA ≥95.0% 1mg ￥464
PACAP-Related Peptide (PRP), human DVAHGILNEAYRKVLDQLSAGKHLQSLVA ≥95.0% 5mg ￥1,392
PACAP (1-27), human, ovine, rat HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 ≥95.0% 1mg ￥442
PACAP (1-27), human, ovine, rat HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 ≥95.0% 5mg ￥1,326
PACAP (6-27), human, ovine, rat FTDSYSRYRKQMAVKKYLAAVL-NH2 ≥95.0% 1mg ￥362
PACAP (6-27), human, ovine, rat FTDSYSRYRKQMAVKKYLAAVL-NH2 ≥95.0% 5mg ￥1,086
Chromostatin, bovine SDEDSDGDRPQASPGLGPGP ≥95.0% 1mg ￥300
Chromostatin, bovine SDEDSDGDRPQASPGLGPGP ≥95.0% 5mg ￥900
Pancreatic Polypeptide (rat) APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 ≥95.0% 1mg ￥684
Pancreatic Polypeptide (rat) APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 ≥95.0% 5mg ￥2,052
Pancreatic Polypeptide (human) APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 ≥95.0% 1mg ￥684
Pancreatic Polypeptide (human) APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 ≥95.0% 5mg ￥2,052
Insulin B (9 - 23) SHLVEALYLVCGERG ≥95.0% 1mg ￥210
Insulin B (9 - 23) SHLVEALYLVCGERG ≥95.0% 5mg ￥630
PAR - 1 Agonist;Protease - Activated Receptor - 1 TFLLRN ≥95.0% 1mg ￥90
PAR - 1 Agonist;Protease - Activated Receptor - 1 TFLLRN ≥95.0% 5mg ￥270
PAR-4 (1-6) amide (human) GYPGQV-NH2 ≥95.0% 1mg ￥100
PAR-4 (1-6) amide (human) GYPGQV-NH2 ≥95.0% 5mg ￥300
PAR-4 (1-6) (human) GYPGQV ≥95.0% 1mg ￥90
PAR-4 (1-6) (human) GYPGQV ≥95.0% 5mg ￥270
PAR-4 (1-6) amide (mouse) GYPGKF-NH2 ≥95.0% 1mg ￥100
PAR-4 (1-6) amide (mouse) GYPGKF-NH2 ≥95.0% 5mg ￥300
PAR-4 (1-6) (mouse) GYPGKF ≥95.0% 1mg ￥90
PAR-4 (1-6) (mouse) GYPGKF ≥95.0% 5mg ￥270
P34cdc2 Kinase Substrate Peptide ADAQHATPPKKKRKVEDPKDF ≥95.0% 1mg ￥315
P34cdc2 Kinase Substrate Peptide ADAQHATPPKKKRKVEDPKDF ≥95.0% 5mg ￥945
Tyrosinase (206-214), human AFLPWHRLF ≥95.0% 1mg ￥136
Tyrosinase (206-214), human AFLPWHRLF ≥95.0% 5mg ￥408
Substrate for Tyrosine Protein Kinase RRLIEDNEYTARG ≥95.0% 1mg ￥194
Substrate for Tyrosine Protein Kinase RRLIEDNEYTARG ≥95.0% 5mg ￥582
S6-1 RRLSSLRA ≥95.0% 1mg ￥122
S6-1 RRLSSLRA ≥95.0% 5mg ￥366
Phosphate Acceptor Peptide RRKASGPPV ≥95.0% 1mg ￥136
Phosphate Acceptor Peptide RRKASGPPV ≥95.0% 5mg ￥408
Malantide RTKRSGSVYEPLKI ≥95.0% 1mg ￥210
Malantide RTKRSGSVYEPLKI ≥95.0% 5mg ￥630
QKRPSQRSKYL QKRPSQRSKYL ≥95.0% 1mg ￥150
QKRPSQRSKYL QKRPSQRSKYL ≥95.0% 5mg ￥450
Protease-Activated Receptor-2, PAR-2 Agonist, amide SLIGKV-NH2 ≥95.0% 1mg ￥110
Protease-Activated Receptor-2, PAR-2 Agonist, amide SLIGKV-NH2 ≥95.0% 5mg ￥330
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 ≥95.0% 1mg ￥426
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 ≥95.0% 5mg ￥1,278
Kemptide LRRASLG ≥95.0% 1mg ￥90
Kemptide LRRASLG ≥95.0% 5mg ￥270
Phosphorylase Kinase b-Subunit (420-436) KRNPGSQKRFPSNCGRD ≥95.0% 1mg ￥255
Phosphorylase Kinase b-Subunit (420-436) KRNPGSQKRFPSNCGRD ≥95.0% 5mg ￥765
Myosin Kinase Inhibiting Peptide KKRAARATS-NH2 ≥95.0% 1mg ￥145
Myosin Kinase Inhibiting Peptide KKRAARATS-NH2 ≥95.0% 5mg ￥435
Syntide 2 PLARTLSVAGLPGKK ≥95.0% 1mg ￥225
Syntide 2 PLARTLSVAGLPGKK ≥95.0% 5mg ￥675
Tyrosinase (192-200), human mouse SEIWRDIDF ≥95.0% 1mg ￥135
Tyrosinase (192-200), human mouse SEIWRDIDF ≥95.0% 5mg ￥405
Tyr-Ile-Tyr-Gly-Ser-Phe-Lys YIYGSFK ≥95.0% 1mg ￥105
Tyr-Ile-Tyr-Gly-Ser-Phe-Lys YIYGSFK ≥95.0% 5mg ￥315
Casein Kinase II Substrate RRREEETEEE ≥95.0% 1mg ￥210
Casein Kinase II Substrate RRREEETEEE ≥95.0% 5mg ￥630
RREEETEEE RREEETEEE ≥95.0% 1mg ￥189
RREEETEEE RREEETEEE ≥95.0% 5mg ￥567
Ser25] Protein Kinase C (19-31) RFARKGSLRQKNV ≥95.0% 1mg ￥195
Ser25] Protein Kinase C (19-31) RFARKGSLRQKNV ≥95.0% 5mg ￥585
[Ala9] Autocamtide 2 KKALRRQEAVDAL ≥95.0% 1mg ￥195
[Ala9] Autocamtide 2 KKALRRQEAVDAL ≥95.0% 5mg ￥585
Autocamtide 2 KKALRRQETVDAL ≥95.0% 1mg ￥195
Autocamtide 2 KKALRRQETVDAL ≥95.0% 5mg ￥585
cAMP Dependent PK Inhibitor (5-22), amide TTYADFIASGRTGRRNAI-NH2 ≥95.0% 1mg ￥280
cAMP Dependent PK Inhibitor (5-22), amide TTYADFIASGRTGRRNAI-NH2 ≥95.0% 5mg ￥840
RR-SRC RRLIEDAEYAARG ≥95.0% 1mg ￥195
RR-SRC RRLIEDAEYAARG ≥95.0% 5mg ￥585
Protein Kinase C (19-35) Peptide RFARKGALRQKNVHEVK ≥95.0% 1mg ￥255
Protein Kinase C (19-35) Peptide RFARKGALRQKNVHEVK ≥95.0% 5mg ￥765
Protein Kinase C (gamma) Peptide NYPLELYERVRTGC ≥95.0% 1mg ￥210
Protein Kinase C (gamma) Peptide NYPLELYERVRTGC ≥95.0% 5mg ￥630
5FAM-RQMSFRL 5FAM-RQMSFRL ≥95.0% 1mg ￥276
5FAM-RQMSFRL 5FAM-RQMSFRL ≥95.0% 5mg ￥828
5FAM-RKRRQTSM 5FAM-RKRRQTSM ≥95.0% 1mg ￥294
5FAM-RKRRQTSM 5FAM-RKRRQTSM ≥95.0% 5mg ￥882
5FAM-RKRSRAEA-NH2 5FAM-RKRSRAEA-NH2 ≥95.0% 1mg ￥304
5FAM-RKRSRAEA-NH2 5FAM-RKRSRAEA-NH2 ≥95.0% 5mg ￥912
5FAM-RPRTSSF 5FAM-RPRTSSF ≥95.0% 1mg ￥276
5FAM-RPRTSSF 5FAM-RPRTSSF ≥95.0% 5mg ￥828
5FAM-RTKRSGSVYEPLKI-NH2 5FAM-RTKRSGSVYEPLKI-NH2 ≥95.0% 1mg ￥420
5FAM-RTKRSGSVYEPLKI-NH2 5FAM-RTKRSGSVYEPLKI-NH2 ≥95.0% 5mg ￥1,260
5FAM-NVKSKIGSTENLK-NH2 5FAM-NVKSKIGSTENLK-NH2 ≥95.0% 1mg ￥402
5FAM-NVKSKIGSTENLK-NH2 5FAM-NVKSKIGSTENLK-NH2 ≥95.0% 5mg ￥402
5FAM-DEEIYEELK-NH2 5FAM-DEEIYEELK-NH2 ≥95.0% 1mg ￥322
5FAM-DEEIYEELK-NH2 5FAM-DEEIYEELK-NH2 ≥95.0% 5mg ￥966
5FAM-QNPSRCSVSLSNVEA-NH2 5FAM-QNPSRCSVSLSNVEA-NH2 ≥95.0% 1mg ￥438
5FAM-QNPSRCSVSLSNVEA-NH2 5FAM-QNPSRCSVSLSNVEA-NH2 ≥95.0% 5mg ￥1,314
5FAM-ERRKSKSGA-NH2 5FAM-ERRKSKSGA-NH2 ≥95.0% 1mg ￥312
5FAM-ERRKSKSGA-NH2 5FAM-ERRKSKSGA-NH2 ≥95.0% 5mg ￥936
Hypercalcemia Malignancy Factor (1-34), human AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA ≥95.0% 1mg ￥578
Hypercalcemia Malignancy Factor (1-34), human AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA ≥95.0% 5mg ￥1,734
Hypercalcemia Malignancy Factor (1-34), amide, human AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 ≥95.0% 1mg ￥588
Hypercalcemia Malignancy Factor (1-34), amide, human AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 ≥95.0% 5mg ￥1,764
Parathyroid Hormone (1-34), rat AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF ≥95.0% 1mg ￥578
Parathyroid Hormone (1-34), rat AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF ≥95.0% 5mg ￥1,734
Parathyroid Hormone (1-34), bovine AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF ≥95.0% 1mg ￥578
Parathyroid Hormone (1-34), bovine AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF ≥95.0% 5mg ￥1,734
Angiotensinogen (1-14), human DRVYIHPFHLVIHN ≥95.0% 1mg ￥210
Angiotensinogen (1-14), human DRVYIHPFHLVIHN ≥95.0% 5mg ￥630
Acetyl Angiotensinogen (1-14), porcine Ac-DRVYIHPFHLLVYS ≥95.0% 1mg ￥220
Acetyl Angiotensinogen (1-14), porcine Ac-DRVYIHPFHLLVYS ≥95.0% 5mg ￥660
Acetyl, Angiotensinogen (1-14), human Ac-DRVYIHPFHLVIHN ≥95.0% 1mg ￥220
Acetyl, Angiotensinogen (1-14), human Ac-DRVYIHPFHLVIHN ≥95.0% 5mg ￥660
Renin Substrate Tetradecapeptide, rat DRVYIHPFHLLYYS ≥95.0% 1mg ￥210
Renin Substrate Tetradecapeptide, rat DRVYIHPFHLLYYS ≥95.0% 5mg ￥630
Angiotensinogen (1-14), porcine DRVYIHPFHLLVYS ≥95.0% 1mg ￥210
Angiotensinogen (1-14), porcine DRVYIHPFHLLVYS ≥95.0% 5mg ￥630
Angiotensinogen (1-13), human DRVYIHPFHLVIH ≥95.0% 1mg ￥195
Angiotensinogen (1-13), human DRVYIHPFHLVIH ≥95.0% 5mg ￥585
P-H-P-F-H-F-F-V-Y-K PHPFHFFVYK ≥95.0% 1mg ￥150
P-H-P-F-H-F-F-V-Y-K PHPFHFFVYK ≥95.0% 5mg ￥450
[Cys8] Renin Substrate Tetradecapeptide, rat DRVYIHPCHLLYYS ≥95.0% 1mg ￥210
[Cys8] Renin Substrate Tetradecapeptide, rat DRVYIHPCHLLYYS ≥95.0% 5mg ￥630
[Leu8] Renin Substrate Tetradecapeptide, rat DRVYIHPLHLLYYS ≥95.0% 1mg ￥210
[Leu8] Renin Substrate Tetradecapeptide, rat DRVYIHPLHLLYYS ≥95.0% 5mg ￥630
[Val8] Renin Substrate Tetradecapeptide, rat DRVYIHPVHLLYYS ≥95.0% 1mg ￥210
[Val8] Renin Substrate Tetradecapeptide, rat DRVYIHPVHLLYYS ≥95.0% 5mg ￥630
Secretin, rat HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 ≥95.0% 1mg ￥417
Secretin, rat HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 ≥95.0% 5mg ￥1,251
Secretin (5-27), porcine TFTSELSRLRDSARLQRLLQGLV-NH2 ≥95.0% 1mg ￥332
Secretin (5-27), porcine TFTSELSRLRDSARLQRLLQGLV-NH2 ≥95.0% 5mg ￥996
Secretin, human HSDGTFTSELSRLREGARLQRLLQGLV-NH2 ≥95.0% 1mg ￥442
Secretin, human HSDGTFTSELSRLREGARLQRLLQGLV-NH2 ≥95.0% 5mg ￥1,362
Selank TKPRPGP ≥98.0% 1mg ￥108
Selank TKPRPGP ≥98.0% 5mg ￥324
Somatostatin 28 (1-14) SANSNPAMAPRERK ≥95.0% 1mg ￥210
Somatostatin 28 (1-14) SANSNPAMAPRERK ≥95.0% 5mg ￥630
Somatostatin1-14 AGCKNFFWKTFTSC (C3&C14 bridge) ≥95.0% 1mg ￥320
Somatostatin1-14 AGCKNFFWKTFTSC (C3&C14 bridge) ≥95.0% 5mg ￥960
RC-160 (Vapreotide) fCYwKVCW-NH2 (C2&C7 bridge) ≥95.0% 1mg ￥300
RC-160 (Vapreotide) fCYwKVCW-NH2 (C2&C7 bridge) ≥95.0% 5mg ￥900
NTB (Naltriben) DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) ≥95.0% 1mg ￥300
NTB (Naltriben) DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) ≥95.0% 5mg ￥900
[DPro2,DPhe7,DTrp9] Substance P R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 ≥95.0% 1mg ￥265
[DPro2,DPhe7,DTrp9] Substance P R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 ≥95.0% 5mg ￥795
MG-132 RPKPQQFFGLM-NH2 ≥95.0% 1mg ￥175
MG-132 RPKPQQFFGLM-NH2 ≥95.0% 5mg ￥525
Pep-1 KETWWETWWTEWSQPKKKRKV ≥95.0% 1mg ￥336
Pep-1 KETWWETWWTEWSQPKKKRKV ≥95.0% 5mg ￥1,008
HIV-1 TAT Protein Peptide YGRKKRRQRRR ≥95.0% 1mg ￥165
HIV-1 TAT Protein Peptide YGRKKRRQRRR ≥95.0% 5mg ￥495
TAT 2-4 YGRKKRRQRRRGYGRKKRRQRRRG ≥95.0% 1mg ￥384
TAT 2-4 YGRKKRRQRRRGYGRKKRRQRRRG ≥95.0% 5mg ￥1,152
Scrambled TRAP Fragment FSLLRN-NH2 ≥95.0% 1mg ￥102
Scrambled TRAP Fragment FSLLRN-NH2 ≥95.0% 5mg ￥306
Hemoglobin (Hb) (64-76) GKKVITAFNEGLK ≥95.0% 1mg ￥195
Hemoglobin (Hb) (64-76) GKKVITAFNEGLK ≥95.0% 5mg ￥585
Thymopoietin II (32-34) RKD ≥95.0% 1mg ￥60
Thymopoietin II (32-34) RKD ≥95.0% 5mg ￥180
Thymopoietin II (32-35) RKDV ≥95.0% 1mg ￥80
Thymopoietin II (32-35) RKDV ≥95.0% 5mg ￥240
Thymopentin RKDVY ≥95.0% 1mg ￥80
Thymopentin RKDVY ≥95.0% 5mg ￥240
Urocortin II, human IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 ≥95.0% 1mg ￥748
Urocortin II, human IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 ≥95.0% 5mg ￥2,244
Urocortin III, mouse FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 ≥95.0% 1mg ￥694
Urocortin III, mouse FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 ≥95.0% 5mg ￥2,082
Urocortin III, human FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 ≥95.0% 1mg ￥694
Urocortin III, human FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 ≥95.0% 5mg ￥2,082
Urocortin, human DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 ≥95.0% 1mg ￥735
Urocortin, human DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 ≥95.0% 5mg ￥2,205
Urocortin, rat DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 ≥95.0% 1mg ￥735
Urocortin, rat DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 ≥95.0% 5mg ￥2,205
Urocortin III, mouse, free acid FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI ≥95.0% 1mg ￥684
Urocortin III, mouse, free acid FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI ≥95.0% 5mg ￥2,052
Urotensin I NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 ≥95.0% 1mg ￥738
Urotensin I NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 ≥95.0% 5mg ￥2,214
VIP, human, porcine, rat, ovine HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 ≥95.0% 1mg ￥486
VIP, human, porcine, rat, ovine HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 ≥95.0% 5mg ￥1,458
PHI, rat HADGVFTSDYSRLLGQISAKKYLESLI-NH2 ≥95.0% 1mg ￥469
PHI, rat HADGVFTSDYSRLLGQISAKKYLESLI-NH2 ≥95.0% 5mg ￥1,407
VIP, guinea pig HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 ≥95.0% 1mg ￥458
VIP, guinea pig HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 ≥95.0% 5mg ￥1,374
Peptide T ASTTTNYT ≥95.0% 1mg ￥120
Peptide T ASTTTNYT ≥95.0% 5mg ￥360
R15K, HIV-1 Inhibitory Peptide RIQRGPGRAFVTIGK ≥95.0% 1mg ￥225
R15K, HIV-1 Inhibitory Peptide RIQRGPGRAFVTIGK ≥95.0% 5mg ￥675